
Skye Bioscience a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders through the development of next-generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substa... Skye Bioscience a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders through the development of next-generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercial differentiation. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.12 | -5.52995391705 | 2.17 | 2.48 | 2.05 | 226306 | 2.31149231 | CS |
4 | 0.04 | 1.99004975124 | 2.01 | 2.48 | 1.78 | 251020 | 2.15806877 | CS |
12 | 0.14 | 7.32984293194 | 1.91 | 3.727 | 1.14 | 734205 | 1.77168532 | CS |
26 | -1.23 | -37.5 | 3.28 | 4.25 | 1.14 | 446569 | 1.99241432 | CS |
52 | -7.61 | -78.7784679089 | 9.66 | 11.1564 | 1.14 | 357248 | 3.13193512 | CS |
156 | -11.45 | -84.8148148148 | 13.5 | 17.6473 | 1.14 | 319377 | 3.54760435 | CS |
260 | -11.45 | -84.8148148148 | 13.5 | 17.6473 | 1.14 | 319377 | 3.54760435 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관